Skip to main content

Table 1 Characteristics of patients

From: MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer

Variable

Number

%

Age (years)

42.58 ± 12.15a

 

Diagnostic category

  

 Normal

541

46.4

 Low-grade CIN

99

8.5

 High-grade CIN

327

28.0

 Cancer

200

17.1

FIGO stage

  

 I

138

69.0

 II

53

26.5

 IV

9

4.5

Tumor grade b

  

 Well/Moderate

117

65.7

 Poor

61

34.3

Cell type

  

 SCC

164

82.0

 AC/ASC

30

15.0

 Others

6

3.0

Tumor size

  

  ≤ 4 cm

145

72.5

  > 4 cm

55

27.5

Lymphovascular invasion c

  

 Negative

95

64.6

 Positive

52

35.4

Lymph node metastasis d

  

 Negative

141

77.5

 Positive

41

22.5

Chemoradiation response e

  

 Good

38

77.6

 Bad

11

22.4

SCC antigen f

  

 Negative

100

66.7

 Positive

50

33.3

HPV test in CIN g

  

 Negative

39

11.5

 Positive

300

88.5

  1. CIN, cervical intraepithelial neoplasia; FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; AC, adenocarcinoma; ASC, adenosquamous carcinoma. amean ± standard deviation, bcalculated only for the 178 cases with available information on tumor grade, ccalculated only for the 147 cases with available information on examined lymphovascular invasion, dcalculated only for the 182 cases with available information on examined lymph nodes, ecalculated only for the 49 cases with available information on chemoradiation response, fcalculated only for the 114 cases with available information on SCC antigen level, gcalculated only for the 339 CIN cases with available information on HPV infection.